Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001127602-20-022135
Filing Date
2020-07-27
Accepted
2020-07-27 18:52:40
Documents
2
Period of Report
2020-07-23

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT form3.html 3  
1 PRIMARY DOCUMENT form3.xml 3 1419
2 POWER OF ATTORNEY (PUBLIC): POA doc1.txt EX-24 1966
  Complete submission text file 0001127602-20-022135.txt   4688
Mailing Address ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320
Business Address ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320 (805)447-1000
AMGEN INC (Issuer) CIK: 0000318154 (see all company filings)

EIN.: 953540776 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address
Business Address
MILES AMY E (Reporting) CIK: 0001248617 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37702 | Film No.: 201051376